期刊文献+

不同类型HPV与宫颈上皮内瘤变和宫颈癌的关系 被引量:2

Relationship between different HPV types, cervical intraepithelial neoplasias and cervical cancer
下载PDF
导出
摘要 目的探讨不同类型人乳头状瘤病毒(HPV)与宫颈上皮内瘤变(CIN)及宫颈癌的关系。方法 80例CIN患者及30例宫颈癌患者,应用第二代杂交捕获试验法(HCⅡ)对HPV进行检测,分析不同类型HPV与宫颈上皮内瘤变和宫颈癌的关系。结果 CINⅠ级患者于20~35岁年龄段占比最高(66.7%);CINⅡ~Ⅲ级患者于20~35岁年龄段占比最高(47.7%);宫颈癌患者于35~50岁年龄段占比最高(30.0%)。〈20岁、20~35岁、35~50岁、50~65岁HPV阳性患者均以HPV6/11分型占比最高,〉65岁HPV阳性患者以HPV18分型占比最高。CINⅠ级患者中以低危型HPV6/11分型占比最高,CINⅡ~Ⅲ级患者中以高危型HPV16分型占比最高,宫颈癌患者中以高危型HPV18分型占比最高。结论 HPV感染率与宫颈病变程度高低成正相关关系,且HPV分型在不同宫颈病变中存在不同差异。 Objective To investigate relationship between different human papilloma virus(HPV) types, cervical intraepithelial neoplasias(CIN) and cervical cancer. Methods A total of 80 CIN patients and 30 cervical cancer patients received hybrid capture test Ⅱ(HCⅡ) for HPV detection. Analysis was made on relationship between different HPV types, cervical intraepithelial neoplasias and cervical cancer. Results Patients aging 20~35 years old showed the highest proportion in grade Ⅰ CIN cases(66.7%); patients aging 20~35 years old showed the highest proportion in grade Ⅱ~Ⅲ CIN cases(47.7%); cervical cancer cases had the highest proportion as 30.0% in patients aging 35~50 years old. HPV6/11 showed the highest proportion in HPV positive patients aging〈 20 years old, 20~35 years old, 35~50 years old and 50~65 years old. Patients aging 〉65 years old had the highest proportion of HPV18. Low risk HPV6/11 accounted for the highest proportion in grade Ⅰ CIN cases, high risk HPV16 accounted for the highest proportion in grade Ⅱ~Ⅲ CIN cases, and high rish HPV18 accounted for the highest proportion in cervical cancer cases. Conclusion HPV infection rate is positively correlated with degree of cervical lesions, and HPV types differ in various cervical lesions.
作者 王蕊 赵继敏
出处 《中国现代药物应用》 2016年第20期16-17,共2页 Chinese Journal of Modern Drug Application
关键词 人乳头状瘤病毒 宫颈上皮内瘤变 宫颈癌 Human papilloma virus Cervical intraepithelial neoplasias Cervical cancer
  • 相关文献

参考文献5

二级参考文献55

  • 1倪晓光,赵平.泛素-蛋白酶体途径与恶性肿瘤关系的研究进展[J].中华肿瘤防治杂志,2007,14(19):1512-1515. 被引量:20
  • 2Zhao Y, Hong L, Wang R, et al. Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma [J]. Dig Dis Sci, 2009,5(3) :586-592.
  • 3Lu Z, Guo Q, Shi A, et al. Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells [J. Mol Biol Rep, 2012,39( 1 ) : 501-507.
  • 4Yong Huang,You Bing Yang,Xiao Hui Zhang,Xue Li Yu,Zhan Bin Wang,Xiang Chao Cheng.MicroRNA-21 gene and cancer[J]. Medical Oncology . 2013 (1)
  • 5WALBOOMERS J M,JACOBS M V,MANOS M M,et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [J].J Pathol,1999,189(1):12-19.
  • 6WRIGHT T J,MASSAD L S,DUNTON C J,et al.2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests [J].Am J Obstet Gynecul,2007,197(4):346-355.
  • 7PETRY K U,MENTON S,MENTON M,et al.Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany:results for 8466 patients [J].Br J Cancer,2003,88(10):1570-1577.
  • 8MEHER C J,SNIJDERS P J,VEN DEN BRULE A J.Screening for cervical cancer:should we test for infection with high-risk HPV? [J].CMAJ,2000,163(5):535-538.
  • 9RIJKAART D C,BERKHOF J,VAN KEMENADE F J,et al.Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening [J].Int J Cancer,2012,130(3):602-610.
  • 10MUlqOZ N,BOSCH F X,CASTELLSAGUE X,et al.Against which human papillomavirus types shall we vaccinate and screen? The international perspective [J].Int J Cancer,2004,111(2):278-285.

共引文献80

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部